Suppr超能文献

帕金森病遗传流行病学(GEO-PD)联盟中 LRRK2 易感性变异的特定人群频率。

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

机构信息

Biostatistics Unit, Mayo Clinic, Jacksonville, Florida, USA.

出版信息

Mov Disord. 2013 Oct;28(12):1740-4. doi: 10.1002/mds.25600. Epub 2013 Aug 2.

Abstract

BACKGROUND

Variants within the leucine-rich repeat kinase 2 gene are recognized as the most frequent genetic cause of Parkinson's disease. Leucine-rich repeat kinase 2 variation related to disease susceptibility displays many features that reflect the nature of complex, late-onset sporadic disorders like Parkinson's disease.

METHODS

The Genetic Epidemiology of Parkinson's Disease Consortium recently performed the largest genetic association study for variants in the leucine-rich repeat kinase 2 gene across 23 different sites in 15 countries.

RESULTS

Herein, we detail the allele frequencies for the novel risk factors (p.A419V and p.M1646T) and the protective haplotype (p.N551K-R1398H-K1423K) nominated in the original publication. Simple population allele frequencies not only can provide insight into the clinical relevance of specific variants but also can help genetically define patient groups.

CONCLUSIONS

Establishing individual patient-based genomic susceptibility profiles that incorporate both risk factors and protective factors will determine future diagnostic and treatment strategies.

摘要

背景

富含亮氨酸重复激酶 2 基因内的变异被认为是帕金森病最常见的遗传原因。与疾病易感性相关的富含亮氨酸重复激酶 2 变异具有许多特征,反映了帕金森病等复杂、迟发性散发性疾病的性质。

方法

帕金森病遗传流行病学研究联盟最近在 15 个国家的 23 个不同地点对富含亮氨酸重复激酶 2 基因中的变异进行了最大的遗传关联研究。

结果

在此,我们详细介绍了在原始出版物中提名的新风险因素(p.A419V 和 p.M1646T)和保护单倍型(p.N551K-R1398H-K1423K)的等位基因频率。简单的人群等位基因频率不仅可以深入了解特定变异的临床相关性,还可以帮助从遗传学上定义患者群体。

结论

建立包含风险因素和保护因素的基于个体患者的基因组易感性特征将确定未来的诊断和治疗策略。

相似文献

6
Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.台湾帕金森病患者中LRRK2的基因变异
PLoS One. 2013 Dec 5;8(12):e82001. doi: 10.1371/journal.pone.0082001. eCollection 2013.

引用本文的文献

5
LRRK2 and Parkinson's disease: from genetics to targeted therapy.LRRK2 与帕金森病:从遗传学研究到靶向治疗。
Ann Clin Transl Neurol. 2023 Jun;10(6):850-864. doi: 10.1002/acn3.51776. Epub 2023 Apr 6.

本文引用的文献

4
Autosomal dominant Parkinson's disease.常染色体显性遗传帕金森病。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S7-10. doi: 10.1016/S1353-8020(11)70005-0.
7
VPS35 mutations in Parkinson disease.帕金森病中的 VPS35 突变。
Am J Hum Genet. 2011 Jul 15;89(1):162-7. doi: 10.1016/j.ajhg.2011.06.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验